Our Pipeline

We are targeting HIV at multiple key nodes to pursue treatment, prevention, and cure.

Deeks et al. Nature Reviews
INSTI - ULA (Once-yearly)
IND Enabling Studies

Yearly ultra-long-acting (ULA) injectable agent targeting HIV integrase

NNRTI
DC Selection
NRTI
Lead Optimization
CRISPR Editing
Discovery

Our long-acting platform technology extends beyond virology.

Buprenorphine LA for Opioid Use Disorder
DC Selection
Undisclosed CNS Disorder
Discovery